Wire Stories
-
696Veristat Congratulates Origin Biosciences for FDA Approval of Nulibry During the Week of Rare Disease Day 2021
Veristat Supported the NDA and Celebrates This Milestone Achievement for Children and Their Families Fighting This Rare Disease SOUTHBOROUGH, Mass.–(BUSINESS WIRE)–#rarediseaseday—Veristat, a...
-
647
Mainstay Medical Announces Commercial Launch of ReActiv8� in Australia
DUBLIN–(BUSINESS WIRE)–Mainstay Medical Holdings plc (�Mainstay� or the �Company�) today announced the commercial launch in Australia of ReActiv8�, its implantable neurostimulation system...
-
670
Westwater Resources Announces Transfer to the NYSE American Stock Exchange
Ticker to Remain �WWR� CENTENNIAL, Colo.–(BUSINESS WIRE)–$WWR #NYSE—Westwater Resources, Inc. (�Westwater�) (NASDAQ: WWR), a battery graphite development company, announced today that it...
-
605
Eros Now Leverages Google Cloud for Artificial Intelligence Led Product Enhancements
AI Architecture to enable Subtitles Across Movies and Originals Content MUMBAI, India–(BUSINESS WIRE)–Eros STX Global Corporation (NYSE: ESGC) (�ErosSTX�), a global entertainment...
-
630
Muchen Launches Oclean Xpro, the Smart Electric Toothbrush
SHENZHEN, China–(BUSINESS WIRE)–At the dawn of this International Women�s Day, Muchen launches the smart electric toothbrush, Oclean Xpro. It has a powerful...
-
637
Criteria Acquires Australian-based Alcami Interactive, a Video Interviewing Platform
Leading assessment company dedicated to helping organizations make better talent decisions, responds to demand for video interviewing solutions LOS ANGELES–(BUSINESS WIRE)–#Criteria—Criteria, a...
-
668
Alteogen Announces Completion of Phase 1 Clinical Trial of Aflibercept Biosimilar in Wet AMD Patients
First clinical trial of Aflibercept biosimilar to be completed in Korea Supported by global formulation and process patents � DAEJEON, South Korea–(BUSINESS...
-
924
Exelixis Enters into Exclusive License Agreement with WuXi Biologics to Support Further Expansion of its Growing Oncology Biologics Pipeline
� Exelixis has exclusive license to panel of monoclonal antibodies against an undisclosed oncology target for biologics applications, leveraging WuXi Biologics integrated...
-
754
Facedrive Partners with Plan International Canada to Combat Child Marriage in Bangladesh
For the rest of 2021, $1 from every Facedrive TraceSCAN device purchase will contribute to Plan International Canada�s campaign to raise $900,000...
-
799
In A First, Kerala Govt�s Global Meet Sets Model To Achieve Carbon Neutrality
THIRUVANANTHAPURAM, India–(BUSINESS WIRE)–#CarbonNeutralEvent–Conforming to the global sustainable development agenda, the second edition of the International Conference on Gender Equality (ICGE) organized by...
